Komori
Statutory disclosure document4572Carna Biosciences,Inc.Pharmaceuticals

Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)

An undertaking was entered into regarding the 1,709,500 new shares to be acquired by Gomi Daisuke (五味 大輔) through a third-party allotment, covering the reporting requirement if the shares are transferred within 2 years after acquisition and consent to their submission to the TSE and public inspection. The allotment is scheduled for 14 October 2026.

Worth reading
58In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
1709500
Shares
Wording
Definitive
How definitive the wording is.

Decision and Details

Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)

Decision14 October 2026 (date of execution)
Period Covered2 years from 14 October 2026 (reporting obligations concerning the transfer of the shares, etc.)
Implementation14 October 2026 (scheduled allotment date)
Going forwardImmediately after execution of this undertaking, Party B will submit a copy to the TSE. If Party A transfers the shares within 2 years from 14 October 2026, Party A will immediately report the details of the transfer to Party B, and Party B will report them to the TSE.
Quantity / scale1,709,500 Party B shares
Reason

To fulfill the obligations concerning reporting upon the transfer of third-party allotment shares, confirmation of ownership status, submission to the TSE and other matters, pursuant to Article 422 of the Tokyo Stock Exchange Listing Regulations and Part II, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules.

Decision and Details
ItemDetails
Matter CoveredConfirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)
Decision Date14 October 2026 (date of execution)
Implementation Date14 October 2026 (scheduled allotment date)
Period Covered2 years from 14 October 2026 (reporting obligations concerning the transfer of the shares, etc.)
Quantity / scale1,709,500 Party B shares
ReasonTo fulfill the obligations concerning reporting upon the transfer of third-party allotment shares, confirmation of ownership status, submission to the TSE and other matters, pursuant to Article 422 of the Tokyo Stock Exchange Listing Regulations and Part II, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules.
Governing RuleArticle 422 of the Tokyo Stock Exchange Listing Regulations and Part II, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules
Future plansImmediately after execution of this undertaking, Party B will submit a copy to the TSE. If Party A transfers the shares within 2 years from 14 October 2026, Party A will immediately report the details of the transfer to Party B, and Party B will report them to the TSE.
Items this document does not state (4)
Decision-Making BodyAmountImpact on Business PerformanceRelated previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide an undertaking regarding reporting on the transfer of third-party allotment shares and related matters, pursuant to the Tokyo Stock Exchange Listing Regulations and Enforcement Rules.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares) | Carna Biosciences,Inc. (4572) timely disclosure | Komori